204 related articles for article (PubMed ID: 8178904)
1. Long-acting injectable contraception with depot medroxyprogesterone acetate.
Kaunitz AM
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1543-9. PubMed ID: 8178904
[TBL] [Abstract][Full Text] [Related]
2. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
3. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
Kaunitz AM
Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
[TBL] [Abstract][Full Text] [Related]
4. Facts about injectable contraception.
Contracept Rep; 1994 Mar; 5(1):1-2. PubMed ID: 12287737
[TBL] [Abstract][Full Text] [Related]
5. Injectable contraception: the USA perspective.
Kaunitz AM
IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920
[TBL] [Abstract][Full Text] [Related]
6. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
Nelson AL
J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701
[TBL] [Abstract][Full Text] [Related]
7. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
Kaunitz AM
J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
[TBL] [Abstract][Full Text] [Related]
8. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
London RS
J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
[TBL] [Abstract][Full Text] [Related]
9. Statement on injectable contraception.
International Planned Parenthood Federation IPPF
IPPF Med Bull; 1982 Dec; 16(6):3-4. PubMed ID: 12338511
[TBL] [Abstract][Full Text] [Related]
10. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
Westhoff C
J Reprod Med; 1996 May; 41(5 Suppl):401-6. PubMed ID: 8725702
[TBL] [Abstract][Full Text] [Related]
11. Use of depo-provera in teens.
Khoiny FE
J Pediatr Health Care; 1996; 10(5):195-201. PubMed ID: 8920351
[TBL] [Abstract][Full Text] [Related]
12. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
Polaneczky M; Guarnaccia M; Alon J; Wiley J
Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
[TBL] [Abstract][Full Text] [Related]
13. Long-term contraception with Depo-Provera: a clinical evaluation.
Mukherjea M; Mukherjee P; Biswas R
Int J Fertil; 1980; 25(2):122-6. PubMed ID: 6117526
[TBL] [Abstract][Full Text] [Related]
14. Long-acting hormonal contraception: assessing impact on bone density, weight, and mood.
Kaunitz AM
Int J Fertil Womens Med; 1999; 44(2):110-7. PubMed ID: 10338269
[TBL] [Abstract][Full Text] [Related]
15. Long-acting contraceptive options.
Kaunitz AM
Int J Fertil Menopausal Stud; 1996; 41(2):69-76. PubMed ID: 8829701
[TBL] [Abstract][Full Text] [Related]
16. New aspects of injectable contraception.
Phillips OP
Int J Fertil Womens Med; 2001; 46(1):31-6. PubMed ID: 11294618
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of depot medroxyprogesterone acetate contraception.
Mishell DR
J Reprod Med; 1996 May; 41(5 Suppl):381-90. PubMed ID: 8725700
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density and depot medroxyprogesterone acetate.
Albertazzi P; Bottazzi M; Steel SA
Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
[TBL] [Abstract][Full Text] [Related]
19. Use of depot medroxyprogesterone acetate contraception in adolescents.
Davis AJ
J Reprod Med; 1996 May; 41(5 Suppl):407-13. PubMed ID: 8725703
[TBL] [Abstract][Full Text] [Related]
20. Depot medroxyprogesterone acetate contraception in women with medical problems.
Frederiksen MC
J Reprod Med; 1996 May; 41(5 Suppl):414-8. PubMed ID: 8725704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
